Model-based analysis to support strategic decision-making: A case study from the development of a 5HT6 antagonist for the treatment of Alzheimer's disease

P3-367 MODEL-BASED ANALYSIS TO SUPPORT STRATEGIC DECISION-MAKING: A CASE STUDY FROM THE DEVELOPMENT OFA 5HT6 ANTAGONIST FOR THE TREATMENT OF ALZHEIMER’S DISEASE James Rogers, Dan Polhamus, Peter Lockwood, Yves Brault, Anne Desmet, Kaori Ito, Klaus Romero, Ruolun Qiu, Brian Corrigan, William Gillespie, Marc Gastonguay, Metrum Research Group, Tariffville, Connecticut, United States; Pfizer, Groton, Connecticut, United States; Pfizer, Paris, Ile-de-France, France; Pfizer, Paris, Ile-de-France, United States; Pfizer Inc., New London, Connecticut, United States; Critical Path Institute, Tucson, Arizona, United States; Pfizer Inc., Groton, Connecticut, United States; Pfizer, New London, Connecticut, United States.